BlackRock’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Buy |
|
|||||
|
2025
Q1 | $361K | Sell |
|
|||||
|
2024
Q4 | $810K | Sell |
|
|||||
|
2024
Q3 | $496K | Sell |
|
|||||
|
2024
Q2 | $520K | Sell |
|
|||||
|
2024
Q1 | $4.74M | Sell |
|
|||||
|
2023
Q4 | $3.63M | Sell |
|
|||||
|
2023
Q3 | $11.4M | Sell |
|
|||||
|
2023
Q2 | $13.3M | Sell |
|
|||||
|
2023
Q1 | $26.9M | Buy |
|
|||||
|
2022
Q4 | $30M | Buy |
|
|||||
|
2022
Q3 | $33.7M | Buy |
|
|||||
|
2022
Q2 | $68.3M | Buy |
|
|||||
|
2022
Q1 | $72.5M | Sell |
|
|||||
|
2021
Q4 | $123M | Buy |
|
|||||
|
2021
Q3 | $137M | Sell |
|
|||||
|
2021
Q2 | $120M | Buy |
|
|||||
|
2021
Q1 | $99.8M | Buy |
|
|||||
|
2020
Q4 | $127M | Buy |
|
|||||
|
2020
Q3 | $76.4M | Buy |
|
|||||
|
2020
Q2 | $74.8M | Buy |
|
|||||
|
2020
Q1 | $38.9M | Sell |
|
|||||
|
2019
Q4 | $75.4M | Buy |
|
|||||
|
2019
Q3 | $62.8M | Buy |
|
|||||
|
2019
Q2 | $77.3M | Buy |
|
|||||
|
2019
Q1 | $139M | Sell |
|
|||||
|
2018
Q4 | $122M | Buy |
|
|||||
|
2018
Q3 | $144M | Buy |
|
|||||
|
2018
Q2 | $124M | Buy |
|
|||||
|
2018
Q1 | $111M | Buy |
|
|||||
|
2017
Q4 | $35.5M | Sell |
|
|||||
|
2017
Q3 | $33M | Buy |
|
|||||
|
2017
Q2 | $26.9M | Buy |
|
|||||
|
2017
Q1 | $35.5M | Buy |
|
|||||
|
2016
Q4 | $177K | Sell |
|
|||||
|
2016
Q3 | $272K | Buy |
|
|||||
|
2016
Q2 | $137K | Buy |
|
|||||
|
2016
Q1 | $20K | Buy |
|
|||||
|
2015
Q4 | $13K | Sell |
|
|||||
|
2015
Q3 | $32K | Buy |
|
|||||
|
2015
Q2 | $17K | Buy |
|
|||||
|
2015
Q1 | $6K | Hold |
|
|||||
|
2014
Q4 | $4K | Buy |
|